| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/17/2004 | CN1483029A Sodium channel modulators derived from 2-piperidylimidazoles |
| 03/17/2004 | CN1483028A Quinolinone derivatives as tyrosine kinase inhibitors |
| 03/17/2004 | CN1483024A Vla-4 inhibitors |
| 03/17/2004 | CN1483019A Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 03/17/2004 | CN1482912A Heteroaryl urea neuropeptide yy5 receptor antagonists |
| 03/17/2004 | CN1482127A Quinacridone derivant and application in organic electroluminescent device thereof |
| 03/17/2004 | CN1142164C Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substituent causing optical activity and process for preparing thereof |
| 03/17/2004 | CN1142159C Prearation method of [(substituted pyridyl) methyl] sulfinyl-IH-benzimidazole compound magnesium salt |
| 03/17/2004 | CN1142153C Benzoylpyridazines |
| 03/17/2004 | CN1142151C 2,4,6-trisubstituted striazine compound and its synthesizing process |
| 03/17/2004 | CN1142149C Novel pyridazine derivatives and drugs containing same as active ingredient |
| 03/17/2004 | CN1142148C Pyridazine derivatives and drugs containing the same as the active ingredient |
| 03/17/2004 | CN1142144C 4-phenyl pyridine derivatives |
| 03/16/2004 | US6706885 Process for preparing integrin antagonist intermediates |
| 03/16/2004 | US6706883 Separating atropisomer by liquid chromatography; heating in dimethylformamide, toluene, or o-dichlorobenzene solvent; chemical reduction |
| 03/16/2004 | US6706882 Process for the preparation of (pyridinylidene)-phthalides |
| 03/16/2004 | US6706749 Substituted phenyl derivatives, their preparation and use |
| 03/16/2004 | US6706743 β3 adrenergic receptor agonists and uses thereof |
| 03/16/2004 | US6706740 Controlling, prevention fungi infections |
| 03/16/2004 | US6706739 Treating enterovirus infection |
| 03/16/2004 | US6706738 Substituted bicyclic heteroaryl compounds and their use as integrin antagonists |
| 03/16/2004 | US6706737 Inhibiting gastric acid secretion are known in the art and include a class of benzimidazole- substituted compounds, one of which is omeprazole |
| 03/16/2004 | US6706735 Nitrogen compounds such as n-(3-(4-benzyl-2-piperidinyl)propyl )-n'-(3-cyanophenyl)urea, used as chemotactic cytokine controllers administered for prophylaxis of asthma, allergies and autoimmune diseases |
| 03/16/2004 | US6706731 With isoquinoline derivatives as antitumor agents |
| 03/16/2004 | US6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 03/16/2004 | US6706716 Compounds specific for the human α1d adrenergic receptor and uses thereof |
| 03/16/2004 | US6706711 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 03/16/2004 | US6706709 Treating, for example, proliferative disorders including cancer |
| 03/16/2004 | US6706703 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (ige) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 03/16/2004 | US6706215 Coating compositions stabilized against damage by light, heat and oxygen |
| 03/16/2004 | US6706021 Anticoagulant for catheters, dialysis machines, syringes, tubes, blood lines and stents; trypsin-like serine proteases such as thrombin; 3-benzylsulfonylamino-6-methyl-1-((2-guanidinooxyethyl) aminocarbonylmethyl)-2-pyridinone |
| 03/16/2004 | CA2294399C Farnesyl transferase inhibitors in combination with hmg coa reductase inhibitors for the treatment of cancer |
| 03/11/2004 | WO2004020448A1 Neutral metallic dendrimer complexes |
| 03/11/2004 | WO2004020441A1 Hetereoaryl nitrile derivatives |
| 03/11/2004 | WO2004020437A1 S-(+)-3-{1-[2-(2,3-dihydro-1h-indol-3-yl)ethyl]-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof |
| 03/11/2004 | WO2004020436A1 Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof |
| 03/11/2004 | WO2004020435A1 Piperidinyl compounds that selectively bind integrins |
| 03/11/2004 | WO2004020434A1 Azaarene derivatives |
| 03/11/2004 | WO2004020433A1 Novel crystals |
| 03/11/2004 | WO2004020432A1 Arylamides |
| 03/11/2004 | WO2004020431A2 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 03/11/2004 | WO2004020415A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 03/11/2004 | WO2004020414A1 Oxytocin inhibitors |
| 03/11/2004 | WO2004020412A1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors |
| 03/11/2004 | WO2004020410A2 Dihydropyridinone derivatives as hne inhibitors |
| 03/11/2004 | WO2004020409A1 Indoles having anti-diabetic activity |
| 03/11/2004 | WO2004020408A1 Indoles having anti-diabetic activity |
| 03/11/2004 | WO2004020371A1 Condensed polycyclic compound and organic light-emitting device using the same |
| 03/11/2004 | WO2004019943A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases |
| 03/11/2004 | WO2004019935A1 -3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases |
| 03/11/2004 | WO2004019889A2 Inhibitors of post-amadori advanced glycation end products |
| 03/11/2004 | WO2004019868A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | WO2004005279A3 Substituted anthranilic amide derivatives and methods of use |
| 03/11/2004 | WO2003101452A8 Process for the preparation of highly pure rabeprazole sodium salt |
| 03/11/2004 | WO2003091264A3 Non nucleoside reverse transcriptase inhibitors |
| 03/11/2004 | WO2003078420A3 Process for making chiral 1,4-disubstituted piperazines |
| 03/11/2004 | WO2003009845A9 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/11/2004 | WO2003006444A3 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 03/11/2004 | WO2002076404A3 Fatty alcohol drug conjugates |
| 03/11/2004 | US20040049083 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/11/2004 | US20040049046 Small molecule inhibitors of rotamase enzyme activity |
| 03/11/2004 | US20040049045 Process for the crystallization of (r)-or (s)-lansoprazole |
| 03/11/2004 | US20040049044 Process for the preparation of pantoprazole and intermediates therefor |
| 03/11/2004 | US20040049039 Treating neurodegenerative, psychotropic, and drug and alcohol induced central and peripheral nervous system disorders. |
| 03/11/2004 | US20040049035 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 03/11/2004 | US20040049032 Inhibitors of protein kinases, especially Aurora kinase; anticancer agents |
| 03/11/2004 | US20040049020 Especially for dyeing paper; red dyeings with good fastness |
| 03/11/2004 | US20040048903 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 03/11/2004 | US20040048901 Increased water solubility and bioabsorption; treatment of CNS disorders such as depression and emesis |
| 03/11/2004 | US20040048898 Benzimidazole compound crystal |
| 03/11/2004 | US20040048896 Treating gastric acid disorders by orally administering a proton pump inhibitor and a mixture of buffers |
| 03/11/2004 | US20040048891 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 03/11/2004 | US20040048884 3-aminoalkyluracil derivatives, e.g., 1-(2,6-Difluorobenzyl)-5-(3-methoxyphenyl)-6-methyl-3-(N-methyl-N-(2 -pyridylethyl)-aminoethyl)uracil; contraceptives; treating lupus, sex hormone related cancer, benign prostatic hypertrophy, etc. |
| 03/11/2004 | US20040048882 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 03/11/2004 | US20040048881 Quinazoline derivatives with anti-tumour activity |
| 03/11/2004 | US20040048880 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
| 03/11/2004 | US20040048875 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 03/11/2004 | US20040048873 Pyrimidine compounds |
| 03/11/2004 | US20040048872 Sedatives, anticonvulsants, hypnotics and general anesthetics. |
| 03/11/2004 | US20040048868 Benzimidazoles |
| 03/11/2004 | US20040048867 Especially quinoline carbonyl pyrrolidines with binding selectivity to benzodiazepine site of GABAA receptor to treatanxiety, depression, a sleep disorder, or cognitive impairment. |
| 03/11/2004 | US20040048866 3-substituted with an oxy-, thio- or amino- group; increasing cGMP levels |
| 03/11/2004 | US20040048864 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/11/2004 | US20040048863 Treating osteoarthritis or rheumatoid arthritis |
| 03/11/2004 | US20040048862 Chemical compounds |
| 03/11/2004 | US20040048853 Compounds, compositions, and methods |
| 03/11/2004 | US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/11/2004 | US20040048850 Activators of soluble guanylate cyclase. |
| 03/11/2004 | US20040048848 Novel gamma secretase inhibitors |
| 03/11/2004 | US20040048844 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| 03/11/2004 | US20040048843 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion |
| 03/11/2004 | US20040048797 Regulation of TNF-alpha |
| 03/11/2004 | DE10238865A1 New carboxamides are melanin-concentrating hormone receptor antagonists, useful for treating e.g. metabolic diseases, diabetes, eating disorders, cardiovascular disease, emotional disorders, reproductive and memory disorders |
| 03/11/2004 | DE10236910A1 Substituierte 1,2,3,4-Tetrahydrochinolinderivate Substituted 1,2,3,4-tetrahydroquinoline |
| 03/11/2004 | CA2501424A1 Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof |
| 03/11/2004 | CA2496887A1 Oxytocin inhibitors |
| 03/11/2004 | CA2496580A1 3-(sulfonamidoethyl)-indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases |
| 03/11/2004 | CA2496452A1 Inhibitors of post-amadori advanced glycation end products |
| 03/11/2004 | CA2495914A1 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | CA2495853A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12 |